[Keynote] Walking towards challenging dreams
summary
Project starts in 1995 and advances over two decades to a first clinical autologous transplant performed around 2013, claiming safety for autologous iPS-derived RPE transplant and subsequent safety in several allogeneic iPS-derived RPE cases. Lab skill is transferred to automation via roboticized culture testing of 48 conditions to solve reproducibility. A new clinical–research hub, Kobe i Center vision park, is built and wins design awards. Plans scale to a multi‑center trial with >15 universities; regulatory change occurs within three years.
AI-written summary · about